Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).

NCT04472429 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

308

Enrollment

INDUSTRY

Sponsor class

Conditions

Squamous Cell Carcinoma of the Anal Canal

Interventions

DRUG: carboplatin
DRUG: paclitaxel
DRUG: retifanlimab

Sponsor

Incyte Corporation